RU2022116422A - PHARMACEUTICAL DOSAGE FORMS OF BRUTONA TYROSINE KINASE INHIBITOR - Google Patents
PHARMACEUTICAL DOSAGE FORMS OF BRUTONA TYROSINE KINASE INHIBITOR Download PDFInfo
- Publication number
- RU2022116422A RU2022116422A RU2022116422A RU2022116422A RU2022116422A RU 2022116422 A RU2022116422 A RU 2022116422A RU 2022116422 A RU2022116422 A RU 2022116422A RU 2022116422 A RU2022116422 A RU 2022116422A RU 2022116422 A RU2022116422 A RU 2022116422A
- Authority
- RU
- Russia
- Prior art keywords
- dosage form
- solid tablet
- high content
- amount
- drug
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title claims 54
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 title 1
- 229940121358 tyrosine kinase inhibitors Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 claims 54
- 239000007787 solid Substances 0.000 claims 53
- 229940079593 drugs Drugs 0.000 claims 42
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 28
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 23
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 22
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 20
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 20
- 239000008108 microcrystalline cellulose Substances 0.000 claims 20
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 20
- 229960001681 Croscarmellose Sodium Drugs 0.000 claims 19
- 239000002177 L01XE27 - Ibrutinib Substances 0.000 claims 18
- XYFPWWZEPKGCCK-GOSISDBHSA-N ibrutinib Chemical compound C1=2C(N)=NC=NC=2N([C@H]2CN(CCC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 XYFPWWZEPKGCCK-GOSISDBHSA-N 0.000 claims 18
- 229960001507 ibrutinib Drugs 0.000 claims 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 18
- 229960001375 Lactose Drugs 0.000 claims 17
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims 17
- 239000008101 lactose Substances 0.000 claims 17
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 16
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 16
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 14
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 14
- 235000019359 magnesium stearate Nutrition 0.000 claims 14
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 10
- 239000003085 diluting agent Substances 0.000 claims 8
- 239000008187 granular material Substances 0.000 claims 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 6
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical group N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 6
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 6
- 239000000126 substance Substances 0.000 claims 6
- 239000011230 binding agent Substances 0.000 claims 5
- WSVLPVUVIUVCRA-RJMJUYIDSA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-RJMJUYIDSA-N 0.000 claims 4
- 229960001021 Lactose Monohydrate Drugs 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 229940057948 Magnesium stearate Drugs 0.000 claims 3
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims 3
- 239000007884 disintegrant Substances 0.000 claims 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 3
- 239000000314 lubricant Substances 0.000 claims 3
- 239000004094 surface-active agent Substances 0.000 claims 3
- 238000005550 wet granulation Methods 0.000 claims 3
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L Calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims 2
- 229960005168 Croscarmellose Drugs 0.000 claims 2
- 229960000913 Crospovidone Drugs 0.000 claims 2
- 229920000881 Modified starch Polymers 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 150000001875 compounds Chemical group 0.000 claims 2
- -1 glidants Substances 0.000 claims 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 235000012239 silicon dioxide Nutrition 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 claims 1
- 229940095672 Calcium Sulfate Drugs 0.000 claims 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 229940097362 Cyclodextrins Drugs 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229940096516 Dextrates Drugs 0.000 claims 1
- 229960001031 Glucose Drugs 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229960002900 Methylcellulose Drugs 0.000 claims 1
- 229940005550 Sodium alginate Drugs 0.000 claims 1
- 229940032147 Starch Drugs 0.000 claims 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims 1
- 229960004793 Sucrose Drugs 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
- 229960002675 Xylitol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 229960001714 calcium phosphate Drugs 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- 235000011132 calcium sulphate Nutrition 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000004927 clay Substances 0.000 claims 1
- 229910052570 clay Inorganic materials 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229920000591 gum Polymers 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 229960001855 mannitol Drugs 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940080313 sodium starch Drugs 0.000 claims 1
- 229920003109 sodium starch glycolate Polymers 0.000 claims 1
- 239000008109 sodium starch glycolate Substances 0.000 claims 1
- 229940079832 sodium starch glycolate Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 235000010356 sorbitol Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (130)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/127,717 | 2015-03-03 | ||
US62/193,518 | 2015-07-16 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017133990A Division RU2017133990A (en) | 2015-03-03 | 2016-03-02 | PHARMACEUTICAL MEDICINAL FORMS OF BRUTON TYROSINKINASE INHIBITOR |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2022116422A true RU2022116422A (en) | 2022-09-16 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017133990A (en) | PHARMACEUTICAL MEDICINAL FORMS OF BRUTON TYROSINKINASE INHIBITOR | |
RU2017106795A (en) | NEW COMPOSITIONS OF BRUTON TYROSINKINASE INHIBITOR | |
BR112020024107A2 (en) | pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and sglt-2 inhibitor and methods of preparing and using them | |
RU2006133902A (en) | SOLID PREPARATION FORMS OF OSPEMIFEN | |
KR20230097211A (en) | High Dosage Strength Tablets of Rucaparib | |
KR20180109992A (en) | A pharmaceutical composition comprising a JAK kinase inhibitor or a pharmaceutically acceptable salt thereof | |
JP2007523210A5 (en) | ||
US20070190020A1 (en) | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture | |
US11911509B2 (en) | Pharmaceutical composition comprising Lenvatinib mesylate | |
JP2004532863A5 (en) | ||
KR20160000762A (en) | Composite formulation for oral administration comprising ezetimibe and rosuvastatin and a process for the preparation thereof | |
WO2005089720A1 (en) | Valsartan tablets and the process for the preparation thereof | |
EA012981B1 (en) | Pharmaceutical composition in the form ofa gastric-resident tablet containing an active principle | |
CA2498506A1 (en) | Novel pharmaceutical formulations of modafinil | |
EP3860606B1 (en) | Pharmaceutical composition comprising lenvatinib esylate or tosylate | |
RU2016106328A (en) | ANTI-TUBERCULAR STABLE PHARMACEUTICAL COMPOSITION IN THE FORM OF A DISPERSABLE TABLET CONTAINING GRANULATED ISONIAZIDE AND GRANULATED RIFAPENTINE, AND METHOD FOR ITS PREPARATION | |
RU2022116422A (en) | PHARMACEUTICAL DOSAGE FORMS OF BRUTONA TYROSINE KINASE INHIBITOR | |
US20130085145A1 (en) | Imatinib mesilate pharmaceutical tablet | |
KR20160054317A (en) | Pharmaceutical Compositions Comprising Lobeglitazone for Oral Administration | |
KR101779513B1 (en) | Pharmaceutical composition comprising the isopropanol extract of artemisia | |
RU2019110098A (en) | SOLID PREPARATION OF ABIRATERONE ACETATE OBTAINED USING THE METHOD OF LIQUID GRANULATION | |
KR102002906B1 (en) | Tablet comprising Celecoxib | |
WO2016012398A1 (en) | Zaltoprofen and muscle relaxant combinations | |
WO2014139836A1 (en) | Pharmaceutical compositions comprising imatinib | |
GR1009119B (en) | Pharmaceutical composition comprising a non-purine selective inhibitor of xanthine oxidase and method for the preparation thereof |